Beijing Tiantan Biological Products Corporation Limited’s Net Profit Rose 46.2% in First Three Quarters of 2023

Beijing Tiantan Biological Products Corporation Limited (北京天坛生物制品股份有限公司) (600161.SH) reported a net profit of 1.2 billion yuan in the first three quarters of 2023, up 46.2% year-on-year.

Meanwhile, the company posted 4 billion yuan in revenue, up 38.1% year-on-year.

At the end of the reporting period, it had 14.6 billion yuan in total assets and 2.1 billion yuan in total liabilities, with a liability-to-asset ratio of 14.5%.